drugset / Trial / NCT00516243

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

NCT00516243

RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.

Timeline

Start
2007-07
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinecatechins Unknown 400 mg Oral
Subject Sinecatechins Unknown 600 mg Oral
Subject Sinecatechins Unknown 800 mg Oral